Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard B Fox

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|November 4, 2008
Cloning and characterization of the monkey histamine H3 receptor isoformsMarina I Strakhova, Gerard B Fox, Tracy L Carr, et al.
Life Sciences|May 30, 2006
Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121Jia Bao Pan, Betty B Yao, Thomas R Miller, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1Ramin Faghih, Wesley Dwight, Robert Gentles, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in ratsMin Zhang, Michael E Ballard, Kathy L Kohlhaas, et al.
Archiv Der Pharmazie|May 19, 2004
D-amino acid homopiperazine amides: discovery of A-320436, a potent and selective non-imidazole histamine H(3)-receptor antagonistMichael P Curtis, Wesley Dwight, John Pratt, et al.
Journal of Medicinal Chemistry|January 7, 2005
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attentionMarlon Cowart, Ramin Faghih, Michael P Curtis, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia modelGerard B Fox, Jia Bao Pan, Timothy A Esbenshade, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterizationGerard B Fox, Jia Bao Pan, Richard J Radek, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|November 4, 2008
Cloning and characterization of the monkey histamine H3 receptor isoformsMarina I Strakhova, Gerard B Fox, Tracy L Carr, et al.
Life Sciences|May 30, 2006
Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121Jia Bao Pan, Betty B Yao, Thomas R Miller, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1Ramin Faghih, Wesley Dwight, Robert Gentles, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in ratsMin Zhang, Michael E Ballard, Kathy L Kohlhaas, et al.
Archiv Der Pharmazie|May 19, 2004
D-amino acid homopiperazine amides: discovery of A-320436, a potent and selective non-imidazole histamine H(3)-receptor antagonistMichael P Curtis, Wesley Dwight, John Pratt, et al.
Journal of Medicinal Chemistry|January 7, 2005
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attentionMarlon Cowart, Ramin Faghih, Michael P Curtis, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia modelGerard B Fox, Jia Bao Pan, Timothy A Esbenshade, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effectsTimothy A Esbenshade, Kathleen M Krueger, Thomas R Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterizationGerard B Fox, Jia Bao Pan, Richard J Radek, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
Pageof 7